EVERY CANCER DESERVES A CURE

RARE CANCERS ARE OFTEN MORE DIFFICULT TO PREVENT, DIAGNOSE, AND TREAT THAN MORE COMMON CANCERS - OFTEN LEADING TO POOR PROGNOSIS AND OUTCOMES FOR PATIENTS

Bubbly and Bourbon on the Bay tickets on sale now!

Bubbly and Bourbon on the Bay tickets on sale now!

You’re invited to Bubbly and Bourbon on the Bay

Presented by

Research Financial Strategies

 Join us on Saturday May 18, 2024 in Annapolis, Md for an unforgettable evening on the Chesapeake Bay with Craig Laughlin and Joe Beninati as they launch their new wine, Broadcast Bubbly!  

Enjoy exquisite views of the bay, wine and bourbon tasting, dinner, live music and entertainment, live and silent auction, and a chance to mingle with Capitals Alumni, staff, and your favorite local celebrities as we come together to make an impact to improve the lives and change the outcomes of women affected by rare gynecologic cancers. We hope you will join us to β€œbottle up!” cancer and take a step towards creating a world where women can have hope.

 

DONATE

Help us fund research initiatives for better education and awareness for rare cancers.

VOLUNTEER

Learn more about volunteering with our foundation and how to get involved.

JOIN US

Save the date for our upcoming events and come out in support of our mission.

 


 
 

OUR CAUSE

We’re on a mission to fund initiatives to advance the care and research around cancers for which there is limited clinical and patient knowledge and understanding. 

 
 
 
 

RARE CANCERS ARE NOT AS RARE AS YOU THINK

In April 2018, Linda Laughlin, was diagnosed with a rare form of endometrial cancer – uterine serous carcinoma β€“ a disease which only affects approximately 6,000 women per year in the United States.

While Linda’s diagnosis came as a shock, it also shed light on the realization that there are hundreds of other rare cancers. Affecting over 100,000 people each year, there is very limited patient and clinical knowledge for these cancers.

 
iStock-941055738.jpg

Every Cancer Deserves a Voice

Rare cancers are often more difficult to prevent, diagnose, and treat than more common cancers. This is due largely to the fact that they historically have not received the same attention or research funding as other more common cancers.  

Rare cancers are generally neglected by the private sector, causing funding to fall to non-profits.



OUR SPONSORS & PARTNERS

We’re so grateful to these fellow organizations and foundation sponsors for supporting our mission to fund research and education for rare cancers.

METIN OMER

NEIL AND EMILY KISHTER